UNITED CAPITAL FINANCIAL ADVISORS, LLC
Position in BSX — Boston Scientific Corp
CIK 1463217
IRVING, TX
Position in BSX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,726,235
-$974,023 QoQ
Shares Held
40,446
-6.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#591
of 1,468 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $79,548,568 across 13 Medical Devices names. BSX ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
527,850 | $41,293,705 | |
| 2 | ABT |
Abbott Laboratories
|
190,899 | $17,322,175 | |
| 3 | SYK |
Stryker Corp
|
24,033 | $7,566,549 | |
| 4 | STE |
STERIS plc
|
25,242 | $5,315,207 | |
| 5 | EW |
Edwards Lifesciences Corp
|
19,972 | $1,806,667 | |
| 6 | BSX |
Boston Scientific Corp
This page
|
40,446 | $1,726,235 | |
| 7 | DXCM |
Dexcom Inc
|
19,104 | $1,286,654 | |
| 8 | PODD |
Insulet Corp
|
8,086 | $1,231,093 |
All Filings in BSX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,726,235 | 40,446 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $2,700,258 | 43,032 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,225,942 | 54,808 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,025,016 | 51,470 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,670,186 | 43,480 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $4,428,026 | 43,894 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,748,760 | 41,970 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,561,332 | 42,498 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,298,800 | 42,836 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,750,969 | 40,166 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,493,518 | 43,133 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $223,185 | 4,227 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $465,714 | 8,610 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $541,574 | 10,825 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $415,550 | 8,981 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $271,497 | 7,010 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $392,080 | 10,520 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $277,565 | 6,267 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $310,281 | 7,151 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $533,773 | 12,483 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $454,485 | 11,759 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $481,550 | 13,395 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $380,227 | 9,951 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||